GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (LTS:0IHV) » Definitions » Cyclically Adjusted Book per Share

Enzo Biochem (LTS:0IHV) Cyclically Adjusted Book per Share : $1.65 (As of Jan. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Enzo Biochem Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Enzo Biochem's adjusted book value per share for the three months ended in Jan. 2025 was $0.890. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.65 for the trailing ten years ended in Jan. 2025.

During the past 12 months, Enzo Biochem's average Cyclically Adjusted Book Growth Rate was 2.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -1.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Enzo Biochem was 11.80% per year. The lowest was -9.60% per year. And the median was 1.90% per year.

As of today (2025-05-29), Enzo Biochem's current stock price is $0.60. Enzo Biochem's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2025 was $1.65. Enzo Biochem's Cyclically Adjusted PB Ratio of today is 0.36.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Enzo Biochem was 5.26. The lowest was 0.17. And the median was 1.72.


Enzo Biochem Cyclically Adjusted Book per Share Historical Data

The historical data trend for Enzo Biochem's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Cyclically Adjusted Book per Share Chart

Enzo Biochem Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.95 1.59 1.40 1.59 1.65

Enzo Biochem Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.72 1.66 1.65 1.70 1.65

Competitive Comparison of Enzo Biochem's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Enzo Biochem's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzo Biochem's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Cyclically Adjusted PB Ratio falls into.


;
;

Enzo Biochem Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Enzo Biochem's adjusted Book Value per Share data for the three months ended in Jan. 2025 was:

Adj_Book= Book Value per Share /CPI of Jan. 2025 (Change)*Current CPI (Jan. 2025)
=0.89/134.0288*134.0288
=0.890

Current CPI (Jan. 2025) = 134.0288.

Enzo Biochem Quarterly Data

Book Value per Share CPI Adj_Book
201504 0.740 99.824 0.994
201507 0.925 100.691 1.231
201510 1.025 100.346 1.369
201601 1.181 99.957 1.584
201604 1.145 100.947 1.520
201607 1.936 101.524 2.556
201610 1.912 101.988 2.513
201701 1.895 102.456 2.479
201704 1.908 103.167 2.479
201707 1.911 103.278 2.480
201710 1.901 104.070 2.448
201801 1.873 104.578 2.400
201804 1.832 105.708 2.323
201807 1.719 106.324 2.167
201810 1.603 106.695 2.014
201901 1.429 106.200 1.803
201904 1.913 107.818 2.378
201907 1.809 108.250 2.240
201910 1.647 108.577 2.033
202001 1.490 108.841 1.835
202004 1.301 108.173 1.612
202007 1.219 109.318 1.495
202010 1.232 109.861 1.503
202101 1.281 110.364 1.556
202104 1.340 112.673 1.594
202107 1.415 115.183 1.647
202110 1.377 116.696 1.582
202201 1.344 118.619 1.519
202204 1.276 121.978 1.402
202207 1.118 125.002 1.199
202210 0.923 125.734 0.984
202301 0.674 126.223 0.716
202304 0.381 127.992 0.399
202307 1.569 128.974 1.630
202310 1.471 129.810 1.519
202401 1.402 130.124 1.444
202404 1.348 132.289 1.366
202407 1.074 132.708 1.085
202410 0.912 133.182 0.918
202501 0.890 134.029 0.890

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Enzo Biochem  (LTS:0IHV) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Enzo Biochem's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.60/1.65
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Enzo Biochem was 5.26. The lowest was 0.17. And the median was 1.72.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Enzo Biochem Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzo Biochem Business Description

Traded in Other Exchanges
Address
21 Executive Boulevard, Farmingdale, NY, USA, 11735
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Enzo Biochem Headlines

No Headlines